Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1Y46
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,561
Award facts
- Contract value 100% obligated
- $26,560.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $26,560.65 delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by January 30, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, delivering a comprehensive portfolio of prescription medications, medical devices, and specialized healthcare commodities to military treatment facilities and veterans' healthcare systems. Dupixent (dupilumab) is a prescription biologic medication indicated for conditions such as atopic dermatitis, asthma, and eczema. The company's non-set-aside contract awards and consistent selection through open competition demonstrate its capability to meet federal procurement requirements for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1Y46?
SPE2DR26F1Y46 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1Y46 worth?
The government has obligated $26,561 on SPE2DR26F1Y46.
Is contract SPE2DR26F1Y46 an order under another contract?
Yes. SPE2DR26F1Y46 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Y46 competed?
The extent of competition for SPE2DR26F1Y46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award